Lahore: Liven Pharma Limited has announced that its Board of Directors will convene an online meeting on November 5, 2025, at 11:30 a.m. The primary agenda for this gathering will be the review and consideration of the company’s annual accounts for the fiscal year ending June 30, 2025.
The company’s announcement comes in compliance with regulatory requirements, as it has declared a Closed Period from October 30, 2025, to November 5, 2025. During this time frame, as stipulated by section 5.6.1(d) of the Pakistan Stock Exchange (PSX) Regulations, no Director, CEO, or Executive of Liven Pharma Limited is permitted to engage in any trading activity involving the company’s shares, whether directly or indirectly.
According to information available from the Pakistan Stock Exchange (PSX), Liven Pharma Limited continues to adhere strictly to these guidelines, ensuring transparent and fair handling of its financial disclosures.
This upcoming meeting and the subsequent financial disclosures are of significant interest to stakeholders, including certificate holders of the exchange, as they provide insights into the company’s financial health and potential future directions.